Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Amicus Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
CONTACT:PRINCETON, N.J., Jan. 02, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that Bradley Campbell, President and Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Monday, January 13, 2025, at 3:00 p.m. PT.
新泽西州普林斯顿，2025年1月2日（环球新闻稿）-- 爱美医疗（纳斯达克：FOLD）今天宣布，总裁兼首席执行官布莱德利·坎贝尔将于2025年1月13日（星期一）下午3:00在加州旧金山举行的第43届J.P.摩根医疗保健大会上进行演讲。
A live audio webcast of the presentation can also be accessed via the investors section of the Amicus Therapeutics corporate website at .
该演讲的现场直播音频网络也可以通过爱美医疗公司网站的投资者部分访问。
About Amicus Therapeutics
Amicus Therapeutics (Nasdaq: FOLD) is a global, patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, Amicus Therapeutics is committed to advancing and expanding a pipeline of cutting-edge, first- or best-in-class medicines for rare diseases. For more information please visit the company's website at , and follow on X and LinkedIn.
关于爱美医疗
爱美医疗（纳斯达克：FOLD）是一家全球性、以患者为中心的生物技术公司，专注于发现、开发和提供用于罕见疾病患者的高质量新药物。凭借卓越的患者关注度，爱美医疗致力于推动和扩展一系列前沿的首创或最佳药物以治疗罕见疾病。如需获取更多信息，请访问公司的官方网站，并在X和LinkedIn上关注我们。
CONTACT:
联系方式：
Investors:
Amicus Therapeutics
Andrew Faughnan
Vice President, Investor Relations
afaughnan@amicusrx.com
(609) 662-3809
投资者：
爱美医疗
安德鲁·福根
副总裁，投资者关系
afaughnan@amicusrx.com
(609) 662-3809
Media:
Amicus Therapeutics
Diana Moore
Head of Global Corporate Affairs and Communications
dmoore@amicusrx.com
(609) 662-5079
媒体：
爱美医疗
戴安娜·摩尔
全球企业事务和通信负责人
dmoore@amicusrx.com
(609) 662-5079
FOLD–G
FOLD–G
